Autoantibodies to 21-hydroxylase as a diagnostic marker of primary autoimmune adrenal insufficiency, including at its potential and latent stages

MLA

N. F. Nuralieva, et al. “Autoantibodies to 21-Hydroxylase as a Diagnostic Marker of Primary Autoimmune Adrenal Insufficiency, Including at Its Potential and Latent Stages.” Alʹmanah Kliničeskoj Mediciny, vol. 48, no. 7, Dec. 2020, pp. 445–58. EBSCOhost, https://doi.org/10.18786/2072-0505-2020-48-023.

APA

N. F. Nuralieva, M. Yu. Yukina, E. A. Troshina, N. M. Malysheva, & L. V. Nikankina. (2020). Autoantibodies to 21-hydroxylase as a diagnostic marker of primary autoimmune adrenal insufficiency, including at its potential and latent stages. Alʹmanah Kliničeskoj Mediciny, 48(7), 445–458. https://doi.org/10.18786/2072-0505-2020-48-023

Chicago

N. F. Nuralieva, M. Yu. Yukina, E. A. Troshina, N. M. Malysheva, and L. V. Nikankina. 2020. “Autoantibodies to 21-Hydroxylase as a Diagnostic Marker of Primary Autoimmune Adrenal Insufficiency, Including at Its Potential and Latent Stages.” Alʹmanah Kliničeskoj Mediciny 48 (7): 445–58. doi:10.18786/2072-0505-2020-48-023.